Yestar Healthcare : POSTPONEMENT OF DATE OF BOARD MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yestar Healthcare Holdings Company Limited

巨 星 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2393)

POSTPONEMENT OF DATE OF BOARD MEETING

Reference is made to the announcement (the ''Announcement'') dated 11 August 2020 of Yestar Healthcare Holdings Company Limited (the ''Company'', together with its subsidiaries, the ''Group'') in relation to the meeting of the board (the ''Board'') of directors (the ''Directors'') of the Company to be held on Monday, 24 August 2020, for the purposes of, among others, considering and approving the unaudited consolidated interim results of the Group for the six months ended 30 June 2020 (the ''2020 Interim Results'').

As additional time is required to complete the 2020 Interim Results, the Board hereby announces that the date of the meeting of the Board to consider and approve, among other things, the 2020 Interim Results of the Company will be postponed to Wednesday, 26 August 2020.

By Order of the Board

Yestar Healthcare Holdings Company Limited

Hartono James

Chairman, CEO and Executive Director

Shanghai, 13 August 2020

As at the date of this announcement, the executive Directors are Mr. Hartono James, Ms. Wang Ying, Ms. Wang Hong and Mr. Chan Chung Man; the independent non-executive Directors are Dr. Hu Yiming, Mr. Karsono Tirtamarta (Kwee Yoe Chiang) and Mr. Sutikno Liky.